Founded by exited entrepreneurs, Science Creates is a Deep Tech ecosystem that enables scientists and engineers to turn their groundbreaking discoveries into disruptive businesses that can revolutionise the health of people and the planet.
By backing founders, we're building capability in the critical technologies — from engineering biology to quantum — that drive economic growth and create the high-skilled jobs of the next decade.
We support our startup community with specialised lab space, expert training and mentoring, a network of partner organisations, and access to investment opportunities. Through our independent charity and public events, we inspire the next generation of scientists and entrepreneurs.




.webp)

Our ethos
We believe the next big breakthroughs will emerge at the intersection of fields like quantum, AI, and biotechnology — and that spinouts are the most powerful way to turn those innovations into global impact.
The first step is empowering those at the forefront of knowledge with the right infrastructure, training, resources and investment.
Science Creates is laying the foundations for bold ideas and innovation to thrive and scale, nationwide.
Designed for flexibility, OMX, our new 30,000 sq ft of lab, office, and meeting space for startups and scaleups is now ready to take new tenants.
We currently welcome applications from service providers working in legal, IT, grants, cloud, bespoke software and marketing.
We invest in Deep Tech at the pre-seed and seed stages — and our endgame is global impact.



Our focus
Deep Tech refers to innovations based on major breakthroughs in science and engineering, often built on years of research and proprietary technology to solve global challenges. Unlike regular tech, it focuses on transformative, long-term solutions in fields like AI, quantum, engineering biology and advanced materials — the UK government's designated frontier industries.
Deep Tech can revolutionise entire industries, create high-skilled jobs and unlock new economic growth while improving lives.
We specialise in Deep Tech because the social, environmental and economic returns are proportional to the ambition. It demands patient capital and deep technical understanding, and that's exactly what we're built to provide.

IsomAb is developing isoform specific antibodies to treat patients with diseases that currently have limited or no treatment options. Its bioinformatics and knowledge-based platform approach has identified the therapeutic antibody ISM-001 as a development candidate for peripheral arterial disease (PAD). By progressing this through clinical trials, it has the potential to significantly improve the wellbeing of those affected by PAD which causes risk factors such as type 2 diabetes, obesity and high blood pressure.

CellVoyant is accelerating the development of novel stem cell-based therapies for chronic diseases. Its technology uses AI-first live cell imaging to predict and optimise stem cell differentiation, enable advanced cell analytics and ultimately unlock the controllable manufacturing of any cell and tissue in the body at scale. Built on foundational research at the University of Bristol, CellVoyant works at the intersection of cell biology, computing, engineering and machine learning to carry out its mission.

LeafyColl is revolutionising skincare and medical treatments with plant-made, human-identical collagen. By combining molecular farming and biotechnology, it harnesses the power of plants to produce high-quality, safe and sustainable collagen for skincare, healthcare and food supplements. With a focus on women’s health, LeafyColl is committed to producing collagen with superior biocompatibility, purity and transdermal absorption to meet the rising industry demands.



Our versatile spaces can welcome a variety of events, from small meetings to 60-person seminars including catering and a fully licensed bar.
